Reduced Mortality and Severe Disability Rates in the SENTIS Trial

BACKGROUND AND PURPOSE: The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of Neu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Schellinger, P.D., Shuaib, A., Köhrmann, M., Liebeskind, D.S., Jovin, T., Hammer, M.D., Sen, S., Huang, D.Y., Solander, S., Gupta, R., Leker, R.R., Saver, J.L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Neuroradiology 2013
Konular:
Interventional
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156593/
https://ncbi.nlm.nih.gov/pubmed/23828106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3613
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller